Quintrio
Home

Stock overview

POMDOCTOR LIMITED Class A Ordinary Shares

POM

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.

Last trade $1.49
Day change -$0.13 (-8.02%)
Day range $1.39 – $1.58
Volume 18,904
Market cap $58M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for POM.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for POM.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Benzinga

Small Chinese Firms Withdraw Wall Street IPO Applications

Three small Chinese companies have formally withdrawn their Nasdaq IPO applications since April, signaling pressure from underwriters amid a regulatory crackdown on suspicious 'pump and dump' listings. The withdrawals reflect increased hostility toward Chinese listings on Wall Street, driven by U.S. political pressure and stricter regulations, with the CSRC approving only two new U.S. listings in the past five months.

GlobeNewswire Inc.

NAVN FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Navan, Inc. Investors to Secure Counsel Before Important April 24 Deadline in Securities Class Action – NAVN

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Navan, Inc., where the firm alleges that offering documents for the October 2025 IPO contained false and misleading information regarding increased sales and marketing expenses. The lead plaintiff deadline is April 24, 2026. Additional lawsuits involve Lufax Holding Ltd and PomDoctor Ltd.

GlobeNewswire Inc.

POM DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important April 13 Deadline in Securities Class Action - POM

Rosen Law Firm is reminding investors in PomDoctor Ltd., Navan, Inc., and Lufax Holding Ltd. of upcoming lead plaintiff deadlines in securities class action lawsuits. PomDoctor investors have until April 13, 2026 to join the class action, which alleges the company was subject to fraudulent stock promotion schemes, insider share dumping, and misleading statements about business operations.

GlobeNewswire Inc.

Bronstein, Gewirtz & Grossman LLC Urges PomDoctor, Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against PomDoctor, Ltd. (NASDAQ: POM) alleging that company defendants made materially false statements and failed to disclose a fraudulent stock promotion scheme involving social media misinformation, coordinated share dumping by insiders using offshore accounts, and artificial trading activity that inflated stock prices during the class period of October 9, 2025 to December 11, 2025.

GlobeNewswire Inc.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines – POM

Pomerantz Law Firm has filed class action lawsuits against PomDoctor Ltd. for alleged securities fraud involving a 'pump and dump' scheme using social media impersonators. PomDoctor's stock surged from $4.00 to $6.09 before crashing 91% to $0.50 on December 10, 2025. Similar lawsuits have been filed against AMC Entertainment Holdings and NuScale Power Corporation. Investors with losses are urged to contact the firm by the April 6, 2026 deadline to potentially become lead plaintiffs.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Dec 8, 2015$4.86Dec 31, 2015recurring
Sep 8, 2015$4.86Sep 30, 2015recurring
Jun 8, 2015$4.86Jun 30, 2015recurring
Mar 6, 2015$4.86Mar 31, 2015recurring
Dec 8, 2014$4.86Dec 31, 2014recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jun 22, 20261-for-18reverse split